Medical e-commerce is the product of transforming the traditional drug circulation industry by using modern management means and internet technology. All participating enterprises, including Haihong Pharmaceutical E-commerce Solution, take centralized drug procurement of medical institutions as the basic business model in the initial stage of implementation, and it is an online electronic trading system with centralized drug procurement of medical institutions as the target market, with the goal of establishing a medical e-commerce market covering the entire medical and health industry. It takes advantage of the industry characteristics of centralized bidding by medical institutions in drug circulation, and mainly provides high-quality online bidding and transaction intermediary services by independent third parties other than drug manufacturers or drug wholesale sellers and consumers represented by medical institutions. The application of the trading system is not based on the informationization of medical institutions and pharmaceutical production and operation enterprises, but directly realizes the leap-forward development of the informationization of medical institutions and pharmaceutical production and operation enterprises while establishing the trading system. All medical institutions in cities above the county level can participate in centralized drug procurement with the help of this network platform. The main advantages of this business model are that it conforms to the national conditions of China's pharmaceutical circulation system reform and can provide agency services for pharmaceutical production and operation enterprises; Provide comprehensive and systematic drug centralized procurement management consulting services for medical institutions, and provide paperless services in the whole process of bidding, tendering and bid evaluation; It can change the information acquisition methods of drug buyers and sellers, and provide high-quality information proliferation services for buyers and sellers and government regulatory authorities, and our company has achieved economic benefits in value-added services. Practice has fully proved that this model is more in line with the interests of all parties and is the only feasible and very effective scheme under the market system conditions at that time. The popularization of this solution in the whole country has consolidated and expanded the achievements of domestic drug circulation system reform, accelerated the pace of establishing a new drug circulation system, and has extremely positive and significant social significance and far-reaching historical significance for solving various social problems in the drug circulation market concerned by all sectors of society. Haihong Holdings' involvement in the drug circulation market with the help of medical e-commerce not only gives the drug circulation system a brand-new operating concept, but also gives the network information industry-e-commerce special responsibility and vitality, further improving the company's investment quality in the new economic field and improving the company's investment strategy and management level.
The further development of this model is also the result of the company's continuous discovery of problems and summary of improvement in the process of popularizing Haihong pharmaceutical e-commerce model nationwide. By constantly improving the technical level and management level, the company strives to transform the company's medical e-commerce model into a comprehensive real-time e-commerce model on the basis of centralized drug procurement in medical institutions, and make contributions to the overall strategy of the development of the pharmaceutical circulation market.
Haihong Holdings' investment in the field of pharmaceutical e-commerce is an important symbol of the transformation of the company's investment from project investment and product investment to industrial investment and industry investment, and an important embodiment of the company's forward-looking and original business strategy.